United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 28, 2026 · Filed Aug 31, 2026

On Aug 28, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$517.51 for US$4.92M under a trading plan, leaving 324,443 shares. Filed Aug 31, 2026 (Form 4).

Sold
9,500 shares
Price
US$517.51 average (US$514.26 to US$524.42)
Value
US$4.92M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 28, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 28, 2026Common StockSale480US$514.26333,463Indirect
Aug 28, 2026Common StockSale1,630US$515.46331,833Indirect
Aug 28, 2026Common StockSale2,386US$516.16329,447Indirect
Aug 28, 2026Common StockSale1,486US$517.11327,961Indirect
Aug 28, 2026Common StockSale1,346US$518.14326,615Indirect
Aug 28, 2026Common StockSale412US$519.19326,203Indirect
Aug 28, 2026Common StockSale751US$520.30325,452Indirect
Aug 28, 2026Common StockSale286US$521.58325,166Indirect
Aug 28, 2026Common StockSale517US$522.40324,649Indirect
Aug 28, 2026Common StockSale6US$523.43324,643Indirect
Aug 28, 2026Common StockSale200US$524.42324,443Indirect

Source

View original at SEC

Related